NCT02134288View on ClinicalTrials.gov

Belatacept for Renal Transplant Recipients With Delayed Graft Function

EARLY_PHASE1TerminatedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 11, 2018

Study Completion Date

January 18, 2019

Conditions

Delayed Graft Function

Interventions

DRUG

Belatacept

DRUG

Everolimus

Trial Locations (1)

43212

The Ohio State Universtiy Wexner Medical Center, Columbus

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Ohio State University

OTHER